Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Donald

Showing results (111-120 of 145) with videos related to

Pageof 15
Sort By:
The Pediatric Infectious Disease Journal|November 16, 2016
Neisseria meningitidis Serogroup B Vaccine, Bivalent rLP2086, Induces Broad Serum Bactericidal Activity Against Diverse Invasive Disease Strains Including Outbreak StrainsShannon L Harris, Robert G K Donald, Julio Cesar Hawkins, et al.
Human Vaccines & Immunotherapeutics|December 15, 2016
Meningococcal serogroup B vaccines: Estimating breadth of coverageRobert G K Donald, Julio Cesar Hawkins, Li Hao, et al.
The Journal of Biological Chemistry|June 26, 2015
A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faeciumSrinivas Kodali, Evgeny Vinogradov, Fiona Lin, et al.
Transplantation|November 14, 2007
The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the ratHenrik Ekberg, Zhongquan Qi, Clara Pahlman, et al.
Clinical and Vaccine Immunology : CVI|August 17, 2012
A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposureJulio Hawkins, Srinivas Kodali, Yury V Matsuka, et al.
Journal of Natural Products|January 17, 2014
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screeningJohn Ondeyka, Alexei V Buevich, R Thomas Williamson, et al.
Molecular and Cellular Biology|October 7, 2009
Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signalingJianghuai Liu, Lucas P Carvalho, Sabyasachi Bhattacharya, et al.
Journal of Medicinal Chemistry|January 19, 2007
Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion propertiesSimon D Guile, John R Bantick, Martin E Cooper, et al.
Microbiology Spectrum|May 3, 2024
Preclinical validation of an <i>Escherichia coli</i> O-antigen glycoconjugate for the prevention of serotype O1 invasive diseaseLaurent Chorro, Duston Ndreu, Axay Patel, et al.
The Journal of Antibiotics|July 29, 2010
Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profilingMichael A Goetz, Chaowei Zhang, Deborah L Zink, et al.
Pageof 15

Showing results (111-120 of 145) with videos related to

Sort By:
Pageof 15
The Pediatric Infectious Disease Journal|November 16, 2016
Neisseria meningitidis Serogroup B Vaccine, Bivalent rLP2086, Induces Broad Serum Bactericidal Activity Against Diverse Invasive Disease Strains Including Outbreak StrainsShannon L Harris, Robert G K Donald, Julio Cesar Hawkins, et al.
Human Vaccines & Immunotherapeutics|December 15, 2016
Meningococcal serogroup B vaccines: Estimating breadth of coverageRobert G K Donald, Julio Cesar Hawkins, Li Hao, et al.
The Journal of Biological Chemistry|June 26, 2015
A Vaccine Approach for the Prevention of Infections by Multidrug-resistant Enterococcus faeciumSrinivas Kodali, Evgeny Vinogradov, Fiona Lin, et al.
Transplantation|November 14, 2007
The specific monocarboxylate transporter-1 (MCT-1) inhibitor, AR-C117977, induces donor-specific suppression, reducing acute and chronic allograft rejection in the ratHenrik Ekberg, Zhongquan Qi, Clara Pahlman, et al.
Clinical and Vaccine Immunology : CVI|August 17, 2012
A recombinant clumping factor A-containing vaccine induces functional antibodies to Staphylococcus aureus that are not observed after natural exposureJulio Hawkins, Srinivas Kodali, Yury V Matsuka, et al.
Journal of Natural Products|January 17, 2014
Isolation, structure elucidation, and biological activity of altersolanol P using Staphylococcus aureus fitness test based genome-wide screeningJohn Ondeyka, Alexei V Buevich, R Thomas Williamson, et al.
Molecular and Cellular Biology|October 7, 2009
Mammalian casein kinase 1alpha and its leishmanial ortholog regulate stability of IFNAR1 and type I interferon signalingJianghuai Liu, Lucas P Carvalho, Sabyasachi Bhattacharya, et al.
Journal of Medicinal Chemistry|January 19, 2007
Optimization of monocarboxylate transporter 1 blockers through analysis and modulation of atropisomer interconversion propertiesSimon D Guile, John R Bantick, Martin E Cooper, et al.
Microbiology Spectrum|May 3, 2024
Preclinical validation of an <i>Escherichia coli</i> O-antigen glycoconjugate for the prevention of serotype O1 invasive diseaseLaurent Chorro, Duston Ndreu, Axay Patel, et al.
The Journal of Antibiotics|July 29, 2010
Coelomycin, a highly substituted 2,6-dioxo-pyrazine fungal metabolite antibacterial agent discovered by Staphylococcus aureus fitness test profilingMichael A Goetz, Chaowei Zhang, Deborah L Zink, et al.
Pageof 15